Evidence that variation in the Peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 3, 2006, Pages 222-226

  Nakamura, Kazuhiko ^a   Yamada, Kazuo ^b   Iwayama, Yoshimi ^b   Toyota, Tomoko ^b   Furukawa, Aizou ^c   Takimoto, Takahiro ^d   Terayama, Hayato ^e   Iwahashi, Kazuhiko ^d   Takei, Nori ^a   Minabe, Yoshio ^a   Sekine, Yoshimoto ^a   Suzuki, Katsuaki ^a   Iwata, Yasuhide ^a   Pillai, Anitha ^a   Nakamoto, Yurie ^c   Ikeda, Kazutaka ^c   Yoshii, Mitsunobu ^c   Fukunishi, Isao ^c   Yoshikawa, Takeo ^b   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d AZABU UNIVERSITY   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Panic disorder; Peripheral benzodiazepine receptor; Polymorphism

Indexed keywords

ARGININE; BENZODIAZEPINE RECEPTOR; HISTIDINE; PERIPHERAL BENZODIAZEPINE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CODON; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; EXON; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PANIC; PBR GENE; PRIORITY JOURNAL; RECEPTOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-A;

EID: 33645963446     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30211     Document Type: Article

References (38)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorder, 4th ed. Washington DC: APA.
2. Chang YJ, McCabe RT, Rennert H, Budarf ML, Sayegh R, Emanuel BS, Skolnick P, Strauss JF III. 1992. The human "peripheral-type" benzodiazepine receptor: Regional mapping of the gene and characterization of the receptor expressed from cDNA. DNA Cell Biol 11:471-480.
3. Cohen J. 1988. Statistical power analysis for the behavioral sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Association. 215p.
4. Cox BJ. 1996. The nature and assessment of catastrophic thoughts in panic disorder. Behav Res Ther 34:363-374.
5. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P. 1998. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3:81-85.
6. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C. 1983. Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors (letter). Lancet 2:98-99.
7. Drugan RC. 1996. Peripheral benzodiazepine receptors: molecular pharmacology to possible physiological significance in stress-induced hypertension. Clin Neuropharmacol 19:475-496.
8. Ferrarese C, Appollonio I, Frigo M, Piolti R, Trabuechi M, Frattola L. 1990. Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: Reversal after chronic diazepam treatment. Acta Psychiatr Scand 82:169-173.
9. Ferrari S, Harley VR, Pontiggia A, Goodfellow PN, Lovell-Badge R, Bianchi ME. 1992. SRY, like HMG1, recognizes sharp angles in DNA. EMBO J 11:4497-4506.
10. Gavish M, Katz Y, Bar-Ami S, Weizman R. 1992. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J Neurochem 58:1589-1601.
11. Gavish M, Laor N, Bidder M, Fisher D, Fonia O, Muller U, Reiss A, Wolmer L, Karp L, Weizman R. 1996. Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology 14:181-186.
12. Goodwin RD, Lieh R, Hoefler M, Pfister H, Bittner A, Beesdo K, Wittchen HU. 2004. Panic attack as a risk factor for severe psychopathology. Am J Psychiatry 161:2207-2214.
13. Hamilton SP, Slager SL, Helleby L, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. 2001. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiatry 6:59-65.
14. Harley VR, Jackson DI, Hextall PJ, Hawkins JR, Berkovitz GD, Sockanathan S, Lovell-Badge R, Goodfellow PN. 1992. DNA binding activity of recombinant SRY from normal males and XY females. Science 255:453-456.
15. Hattori E, Yamada K, Toyota T, Yoshitsugu K, Toru M, Shibuya H, Yoshikawa T. 2001. Association studies of the CT repeat polymorphism in the 50 upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. Am J Med Genet 105:779-782.
16. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568-1578.
17. Inada Y, Yoneda H, Koh J, Sakai J, Himei A, Kinoshita Y, Akabame K, Hiraoka Y, Sakai T. 2003. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res 118:25-31.
18. Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB. 1998. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry 43:306-309.
19. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, Fourie O. 1999. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284-285.
20. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
21. Lin D, Chang YJ, Strauss JF III, Miller WL. 1993. The human peripheral benzodiazepine receptor gene: Cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 18:643-650.
22. Marazziti D, Rotondo A, Martini C, Giannaccini G, Lucacchini A, Pancioli-Guadagnucci ML, Diamond BI, Borison R, Cassano GB. 1994. Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive compulsive disorder. Neuropsychobiology 29:8-11.
23. Nakamura K, Fukunishi I, Nakamoto Y, Iwahashi K, Yoshii M. 2002. Peripheral-type benzodiazepine receptors on platelets correlate with the degrees of anxiety in normal human subjects. Psychopharmacology 162:301-303.
24. Pontiggia A, Rimini R, Harley VR, Goodfellow PN, Lovell-Badge R, Bianchi ME. 1994. Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J 13:6115-6124.
25. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, Pesich R, Hebert J, Chen YD, Dzau VJ, Curb D, Olshen R, Risch N, Cox DR, Botstein D. 2001. High-throughput genotyping with single nucleotide polymorphism. Genome Res 11:1262-1268.
26. Riond J, Mattei MG, Kaghad M, Dumont X, Guillemot JC, Le Fur G, Caput D, Ferrara P. 1991. Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur J Biochem 195:305-311.
27. Rocca P, Ferrero P, Gualerzi A, Zanalda E, Maina G, Bergamasco B, Ravizza L. 1991. Peripheral-type benzodiazepine receptors in anxiety disorders. Acta Psychiatr Scand 84:537-544.
28. Schmidt NB, Lerew DR, Jackson RJ. 1997. The role of anxiety sensitivity in the pathogenesis of panic: Prospective evaluation of spontaneous panic attacks during acute stress. J Abnorm Psychol 106:355-364.
29. Schneider S, Kueffer JM, Roessli D, Excoffier L. 1997. Arlequin ver.1.1: A software for population genetic data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
30. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
31. Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E. 1993. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 88:85-92.
32. Stein MB, Jang KL, Livesley WJ. 1999. Heritability of anxiety sensitivity: A twin study. Am J Psychiatry 156:246-251.
33. Wang Z, Valdes J, Noyes R, Zoega T, Crowe RR. 1998. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. Am J Med Genet 81:228-234.
34. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK. 1997. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305-309.
35. Weizman R, Tanne Z, Granek M, Karp L, Golomb M, Tyano S, Gavish M. 1987. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur J Pharmacol 138:289-292.
36. Weizman A, Burgin R, Harel Y, Karp L, Gavish M. 1995. Platelet peripheral-type benzodiazepine receptor in major depression. J Affect Disord 33:257-261.
37. Woo JM, Yoon KS, Yu BH. 2002. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 159:1785-1787.
38. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T. 2001. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108:837-848.